Rockefeller Capital Management L.P. Decreases Holdings in SPDR S&P Pharmaceuticals ETF $XPH

Rockefeller Capital Management L.P. reduced its position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 64.4% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 20,395 shares of the company’s stock after selling 36,945 shares during the period. Rockefeller Capital Management L.P.’s holdings in SPDR S&P Pharmaceuticals ETF were worth $828,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. Blair William & Co. IL purchased a new stake in SPDR S&P Pharmaceuticals ETF during the 1st quarter valued at about $30,000. Wharton Business Group LLC boosted its holdings in shares of SPDR S&P Pharmaceuticals ETF by 9.9% during the 1st quarter. Wharton Business Group LLC now owns 48,205 shares of the company’s stock worth $2,111,000 after purchasing an additional 4,360 shares during the last quarter. Citigroup Inc. grew its position in shares of SPDR S&P Pharmaceuticals ETF by 25,086,800.0% in the first quarter. Citigroup Inc. now owns 250,869 shares of the company’s stock valued at $10,988,000 after purchasing an additional 250,868 shares in the last quarter. Simplex Trading LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the first quarter valued at approximately $27,000. Finally, SVB Wealth LLC increased its holdings in shares of SPDR S&P Pharmaceuticals ETF by 429.6% in the first quarter. SVB Wealth LLC now owns 32,933 shares of the company’s stock valued at $1,442,000 after purchasing an additional 26,715 shares during the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Up 1.1%

Shares of NYSEARCA:XPH opened at $54.78 on Thursday. SPDR S&P Pharmaceuticals ETF has a 52-week low of $35.22 and a 52-week high of $54.90. The stock has a market cap of $202.69 million, a P/E ratio of 14.28 and a beta of 0.60. The business has a fifty day moving average of $49.12 and a two-hundred day moving average of $45.13.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.